Index by author

October 01, 1996; Volume 7,Issue 10

A

  1. Agarwal, A

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  2. Agarwal, G

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  3. Albers, F J

    1. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
      E C Kovalik, J R Raymond, F J Albers, M Berkoben, D W Butterly, B Montella and P J Conlon
      JASN October 1996, 7 (10) 2264-2267; DOI: https://doi.org/10.1681/ASN.V7102264

  4. Alleyne, S

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  5. Amuchastegui, S

    1. The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes.
      N Perico, S Amuchastegui, M Bontempelli and G Remuzzi
      JASN October 1996, 7 (10) 2254-2258; DOI: https://doi.org/10.1681/ASN.V7102254

B

  1. Badenas, C

    1. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
      R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert and X Estivill
      JASN October 1996, 7 (10) 2142-2151; DOI: https://doi.org/10.1681/ASN.V7102142

  2. Barrett, T W

    1. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
      S Sundaram, T W Barrett, K B Meyer, C Perrella, M C Neto, A J King and B J Pereira
      JASN October 1996, 7 (10) 2183-2191; DOI: https://doi.org/10.1681/ASN.V7102183

  3. Bennett, W M

    1. Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management.
      M Sutters, C L Gaboury and W M Bennett
      JASN October 1996, 7 (10) 2056-2061; DOI: https://doi.org/10.1681/ASN.V7102056

  4. Berkoben, M

    1. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
      E C Kovalik, J R Raymond, F J Albers, M Berkoben, D W Butterly, B Montella and P J Conlon
      JASN October 1996, 7 (10) 2264-2267; DOI: https://doi.org/10.1681/ASN.V7102264

  5. Bernardini, J

    1. Peritonitis influences mortality in peritoneal dialysis patients.
      L F Fried, J Bernardini, J R Johnston and B Piraino
      JASN October 1996, 7 (10) 2176-2182; DOI: https://doi.org/10.1681/ASN.V7102176

  6. Bohlender, J

    1. Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats.
      A Lippoldt, V Gross, J Bohlender, U Ganten and F C Luft
      JASN October 1996, 7 (10) 2119-2129; DOI: https://doi.org/10.1681/ASN.V7102119

  7. Bontempelli, M

    1. The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes.
      N Perico, S Amuchastegui, M Bontempelli and G Remuzzi
      JASN October 1996, 7 (10) 2254-2258; DOI: https://doi.org/10.1681/ASN.V7102254

  8. Boyle, D H

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  9. Breton, S

    1. Cell volume increases of physiologic amplitude activate basolateral K and CI conductances in the rabbit proximal convoluted tubule.
      S Breton, M Marsolais, J Y Lapointe and R Laprade
      JASN October 1996, 7 (10) 2072-2087; DOI: https://doi.org/10.1681/ASN.V7102072

  10. Buck, C

    1. Why is it difficult for staff to discuss advance directives with chronic dialysis patients?
      E Perry, R Swartz, L Smith-Wheelock, J Westbrook and C Buck
      JASN October 1996, 7 (10) 2160-2168; DOI: https://doi.org/10.1681/ASN.V7102160

  11. Budreau, A M

    1. Role of conserved peptide in taurine transporter inactivation modulated by protein kinase C.
      X Han, A M Budreau and R W Chesney
      JASN October 1996, 7 (10) 2088-2096; DOI: https://doi.org/10.1681/ASN.V7102088

  12. Butterly, D W

    1. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
      E C Kovalik, J R Raymond, F J Albers, M Berkoben, D W Butterly, B Montella and P J Conlon
      JASN October 1996, 7 (10) 2264-2267; DOI: https://doi.org/10.1681/ASN.V7102264

C

  1. Cao, L

    1. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
      X Ni, Y Cheng, L Cao, D G Gardner and M H Humphreys
      JASN October 1996, 7 (10) 2110-2118; DOI: https://doi.org/10.1681/ASN.V7102110

  2. Carlton, S G

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  3. Cheng, Y

    1. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
      X Ni, Y Cheng, L Cao, D G Gardner and M H Humphreys
      JASN October 1996, 7 (10) 2110-2118; DOI: https://doi.org/10.1681/ASN.V7102110

  4. Chesney, R W

    1. Role of conserved peptide in taurine transporter inactivation modulated by protein kinase C.
      X Han, A M Budreau and R W Chesney
      JASN October 1996, 7 (10) 2088-2096; DOI: https://doi.org/10.1681/ASN.V7102088

  5. Conlon, P J

    1. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
      E C Kovalik, J R Raymond, F J Albers, M Berkoben, D W Butterly, B Montella and P J Conlon
      JASN October 1996, 7 (10) 2264-2267; DOI: https://doi.org/10.1681/ASN.V7102264

  6. Cruz, I

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

D

  1. Darnell, A

    1. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
      R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert and X Estivill
      JASN October 1996, 7 (10) 2142-2151; DOI: https://doi.org/10.1681/ASN.V7102142

  2. DeJonge, K

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

  3. Delaney, V B

    1. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred.
      M R Pollak, V B Delaney, R M Graham and S C Hebert
      JASN October 1996, 7 (10) 2244-2248; DOI: https://doi.org/10.1681/ASN.V7102244

  4. de Lemos, J A

    1. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis.
      J A de Lemos and L D Hillis
      JASN October 1996, 7 (10) 2044-2054; DOI: https://doi.org/10.1681/ASN.V7102044

  5. Ding, Y

    1. Antithrombin III inhibits mesangial cell proliferation.
      M V Pahl, N D Vaziri, F Oveisi, J Wang and Y Ding
      JASN October 1996, 7 (10) 2249-2253; DOI: https://doi.org/10.1681/ASN.V7102249

E

  1. Estivill, X

    1. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
      R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert and X Estivill
      JASN October 1996, 7 (10) 2142-2151; DOI: https://doi.org/10.1681/ASN.V7102142

F

  1. Falkenhain, M E

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  2. Frei, U

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

  3. Fried, L F

    1. Peritonitis influences mortality in peritoneal dialysis patients.
      L F Fried, J Bernardini, J R Johnston and B Piraino
      JASN October 1996, 7 (10) 2176-2182; DOI: https://doi.org/10.1681/ASN.V7102176

G

  1. Gaboury, C L

    1. Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management.
      M Sutters, C L Gaboury and W M Bennett
      JASN October 1996, 7 (10) 2056-2061; DOI: https://doi.org/10.1681/ASN.V7102056

  2. Gahl, G M

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

  3. Ganten, U

    1. Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats.
      A Lippoldt, V Gross, J Bohlender, U Ganten and F C Luft
      JASN October 1996, 7 (10) 2119-2129; DOI: https://doi.org/10.1681/ASN.V7102119

  4. Gardner, D G

    1. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
      X Ni, Y Cheng, L Cao, D G Gardner and M H Humphreys
      JASN October 1996, 7 (10) 2110-2118; DOI: https://doi.org/10.1681/ASN.V7102110

  5. Glass, W F

    1. Extracellular matrix distribution and hillock formation in human mesangial cells in culture without serum.
      W F Glass, P R Teng and L B Haney
      JASN October 1996, 7 (10) 2230-2243; DOI: https://doi.org/10.1681/ASN.V7102230

  6. Graham, R M

    1. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred.
      M R Pollak, V B Delaney, R M Graham and S C Hebert
      JASN October 1996, 7 (10) 2244-2248; DOI: https://doi.org/10.1681/ASN.V7102244

  7. Gross, V

    1. Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats.
      A Lippoldt, V Gross, J Bohlender, U Ganten and F C Luft
      JASN October 1996, 7 (10) 2119-2129; DOI: https://doi.org/10.1681/ASN.V7102119

H

  1. Han, X

    1. Role of conserved peptide in taurine transporter inactivation modulated by protein kinase C.
      X Han, A M Budreau and R W Chesney
      JASN October 1996, 7 (10) 2088-2096; DOI: https://doi.org/10.1681/ASN.V7102088

  2. Haney, L B

    1. Extracellular matrix distribution and hillock formation in human mesangial cells in culture without serum.
      W F Glass, P R Teng and L B Haney
      JASN October 1996, 7 (10) 2230-2243; DOI: https://doi.org/10.1681/ASN.V7102230

  3. Hebert, L A

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  4. Hebert, S C

    1. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred.
      M R Pollak, V B Delaney, R M Graham and S C Hebert
      JASN October 1996, 7 (10) 2244-2248; DOI: https://doi.org/10.1681/ASN.V7102244

  5. Hillis, L D

    1. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis.
      J A de Lemos and L D Hillis
      JASN October 1996, 7 (10) 2044-2054; DOI: https://doi.org/10.1681/ASN.V7102044

  6. Hiremath, L

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  7. Hubbard, J I

    1. Water transport in cultured cells from the rat inner medullary collecting duct.
      J I Hubbard
      JASN October 1996, 7 (10) 2062-2071; DOI: https://doi.org/10.1681/ASN.V7102062

  8. Humphreys, M H

    1. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
      X Ni, Y Cheng, L Cao, D G Gardner and M H Humphreys
      JASN October 1996, 7 (10) 2110-2118; DOI: https://doi.org/10.1681/ASN.V7102110

  9. Huston, J

    1. Follow-up of intracranial aneurysms in autosomal dominant polycystic kidney disease by magnetic resonance angiography.
      J Huston, V E Torres, D O Wiebers and W I Schievink
      JASN October 1996, 7 (10) 2135-2141; DOI: https://doi.org/10.1681/ASN.V7102135

  10. Hymes, J

    1. Angiotensin in progressive renal diseases: theory and practice.
      T Matsusaka, J Hymes and I Ichikawa
      JASN October 1996, 7 (10) 2025-2043; DOI: https://doi.org/10.1681/ASN.V7102025

I

  1. Ichikawa, I

    1. Angiotensin in progressive renal diseases: theory and practice.
      T Matsusaka, J Hymes and I Ichikawa
      JASN October 1996, 7 (10) 2025-2043; DOI: https://doi.org/10.1681/ASN.V7102025

  2. Ikeda, M

    1. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells.
      M Ikeda, U Ikeda, M Takahashi, K Shimada, S Minota and S Kano
      JASN October 1996, 7 (10) 2213-2218; DOI: https://doi.org/10.1681/ASN.V7102213

  3. Ikeda, U

    1. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells.
      M Ikeda, U Ikeda, M Takahashi, K Shimada, S Minota and S Kano
      JASN October 1996, 7 (10) 2213-2218; DOI: https://doi.org/10.1681/ASN.V7102213

  4. Ishidoya, S

    1. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
      J J Morrissey, S Ishidoya, R McCracken and S Klahr
      JASN October 1996, 7 (10) 2202-2212; DOI: https://doi.org/10.1681/ASN.V7102202

J

  1. Johnston, J R

    1. Peritonitis influences mortality in peritoneal dialysis patients.
      L F Fried, J Bernardini, J R Johnston and B Piraino
      JASN October 1996, 7 (10) 2176-2182; DOI: https://doi.org/10.1681/ASN.V7102176

  2. Jörres, A

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

K

  1. Kano, S

    1. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells.
      M Ikeda, U Ikeda, M Takahashi, K Shimada, S Minota and S Kano
      JASN October 1996, 7 (10) 2213-2218; DOI: https://doi.org/10.1681/ASN.V7102213

  2. Kaplan, A A

    1. Protein losses in continuous renal replacement therapies.
      M H Mokrzycki and A A Kaplan
      JASN October 1996, 7 (10) 2259-2263; DOI: https://doi.org/10.1681/ASN.V7102259

  3. Kashihara, N

    1. Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation.
      Y Maeshima, N Kashihara, H Sugiyama, H Makino and Z Ota
      JASN October 1996, 7 (10) 2219-2229; DOI: https://doi.org/10.1681/ASN.V7102219

  4. Kimmel, P L

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  5. King, A J

    1. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
      S Sundaram, T W Barrett, K B Meyer, C Perrella, M C Neto, A J King and B J Pereira
      JASN October 1996, 7 (10) 2183-2191; DOI: https://doi.org/10.1681/ASN.V7102183

  6. Klahr, S

    1. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
      J J Morrissey, S Ishidoya, R McCracken and S Klahr
      JASN October 1996, 7 (10) 2202-2212; DOI: https://doi.org/10.1681/ASN.V7102202

  7. Kovac, J A

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  8. Kovalik, E C

    1. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
      E C Kovalik, J R Raymond, F J Albers, M Berkoben, D W Butterly, B Montella and P J Conlon
      JASN October 1996, 7 (10) 2264-2267; DOI: https://doi.org/10.1681/ASN.V7102264

L

  1. Ladson-Wofford, S E

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  2. Lang, J

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

  3. Lapointe, J Y

    1. Cell volume increases of physiologic amplitude activate basolateral K and CI conductances in the rabbit proximal convoluted tubule.
      S Breton, M Marsolais, J Y Lapointe and R Laprade
      JASN October 1996, 7 (10) 2072-2087; DOI: https://doi.org/10.1681/ASN.V7102072

  4. Laprade, R

    1. Cell volume increases of physiologic amplitude activate basolateral K and CI conductances in the rabbit proximal convoluted tubule.
      S Breton, M Marsolais, J Y Lapointe and R Laprade
      JASN October 1996, 7 (10) 2072-2087; DOI: https://doi.org/10.1681/ASN.V7102072

  5. Lippoldt, A

    1. Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats.
      A Lippoldt, V Gross, J Bohlender, U Ganten and F C Luft
      JASN October 1996, 7 (10) 2119-2129; DOI: https://doi.org/10.1681/ASN.V7102119

  6. Ludat, K

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

  7. Luft, F C

    1. Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats.
      A Lippoldt, V Gross, J Bohlender, U Ganten and F C Luft
      JASN October 1996, 7 (10) 2119-2129; DOI: https://doi.org/10.1681/ASN.V7102119

M

  1. Maeshima, Y

    1. Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation.
      Y Maeshima, N Kashihara, H Sugiyama, H Makino and Z Ota
      JASN October 1996, 7 (10) 2219-2229; DOI: https://doi.org/10.1681/ASN.V7102219

  2. Makino, H

    1. Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation.
      Y Maeshima, N Kashihara, H Sugiyama, H Makino and Z Ota
      JASN October 1996, 7 (10) 2219-2229; DOI: https://doi.org/10.1681/ASN.V7102219

  3. Marsolais, M

    1. Cell volume increases of physiologic amplitude activate basolateral K and CI conductances in the rabbit proximal convoluted tubule.
      S Breton, M Marsolais, J Y Lapointe and R Laprade
      JASN October 1996, 7 (10) 2072-2087; DOI: https://doi.org/10.1681/ASN.V7102072

  4. Matsusaka, T

    1. Angiotensin in progressive renal diseases: theory and practice.
      T Matsusaka, J Hymes and I Ichikawa
      JASN October 1996, 7 (10) 2025-2043; DOI: https://doi.org/10.1681/ASN.V7102025

  5. McClellan, W M

    1. Early death in dialysis patients: risk factors and impact on incidence and mortality rates.
      J M Soucie and W M McClellan
      JASN October 1996, 7 (10) 2169-2175; DOI: https://doi.org/10.1681/ASN.V7102169

  6. McCracken, R

    1. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
      J J Morrissey, S Ishidoya, R McCracken and S Klahr
      JASN October 1996, 7 (10) 2202-2212; DOI: https://doi.org/10.1681/ASN.V7102202

  7. Meyer, K B

    1. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
      S Sundaram, T W Barrett, K B Meyer, C Perrella, M C Neto, A J King and B J Pereira
      JASN October 1996, 7 (10) 2183-2191; DOI: https://doi.org/10.1681/ASN.V7102183

  8. Minota, S

    1. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells.
      M Ikeda, U Ikeda, M Takahashi, K Shimada, S Minota and S Kano
      JASN October 1996, 7 (10) 2213-2218; DOI: https://doi.org/10.1681/ASN.V7102213

  9. Mokrzycki, M H

    1. Protein losses in continuous renal replacement therapies.
      M H Mokrzycki and A A Kaplan
      JASN October 1996, 7 (10) 2259-2263; DOI: https://doi.org/10.1681/ASN.V7102259

  10. Montella, B

    1. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
      E C Kovalik, J R Raymond, F J Albers, M Berkoben, D W Butterly, B Montella and P J Conlon
      JASN October 1996, 7 (10) 2264-2267; DOI: https://doi.org/10.1681/ASN.V7102264

  11. Morrissey, J J

    1. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
      J J Morrissey, S Ishidoya, R McCracken and S Klahr
      JASN October 1996, 7 (10) 2202-2212; DOI: https://doi.org/10.1681/ASN.V7102202

N

  1. Nahman, N S

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  2. Neto, M C

    1. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
      S Sundaram, T W Barrett, K B Meyer, C Perrella, M C Neto, A J King and B J Pereira
      JASN October 1996, 7 (10) 2183-2191; DOI: https://doi.org/10.1681/ASN.V7102183

  3. Ni, X

    1. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
      X Ni, Y Cheng, L Cao, D G Gardner and M H Humphreys
      JASN October 1996, 7 (10) 2110-2118; DOI: https://doi.org/10.1681/ASN.V7102110

  4. Nicolau, C

    1. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
      R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert and X Estivill
      JASN October 1996, 7 (10) 2142-2151; DOI: https://doi.org/10.1681/ASN.V7102142

O

  1. Ota, Z

    1. Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation.
      Y Maeshima, N Kashihara, H Sugiyama, H Makino and Z Ota
      JASN October 1996, 7 (10) 2219-2229; DOI: https://doi.org/10.1681/ASN.V7102219

  2. Oveisi, F

    1. Antithrombin III inhibits mesangial cell proliferation.
      M V Pahl, N D Vaziri, F Oveisi, J Wang and Y Ding
      JASN October 1996, 7 (10) 2249-2253; DOI: https://doi.org/10.1681/ASN.V7102249

P

  1. Pahl, M V

    1. Antithrombin III inhibits mesangial cell proliferation.
      M V Pahl, N D Vaziri, F Oveisi, J Wang and Y Ding
      JASN October 1996, 7 (10) 2249-2253; DOI: https://doi.org/10.1681/ASN.V7102249

  2. Pereira, B J

    1. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
      S Sundaram, T W Barrett, K B Meyer, C Perrella, M C Neto, A J King and B J Pereira
      JASN October 1996, 7 (10) 2183-2191; DOI: https://doi.org/10.1681/ASN.V7102183

  3. Perico, N

    1. The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes.
      N Perico, S Amuchastegui, M Bontempelli and G Remuzzi
      JASN October 1996, 7 (10) 2254-2258; DOI: https://doi.org/10.1681/ASN.V7102254

  4. Perrella, C

    1. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
      S Sundaram, T W Barrett, K B Meyer, C Perrella, M C Neto, A J King and B J Pereira
      JASN October 1996, 7 (10) 2183-2191; DOI: https://doi.org/10.1681/ASN.V7102183

  5. Perry, E

    1. Why is it difficult for staff to discuss advance directives with chronic dialysis patients?
      E Perry, R Swartz, L Smith-Wheelock, J Westbrook and C Buck
      JASN October 1996, 7 (10) 2160-2168; DOI: https://doi.org/10.1681/ASN.V7102160

  6. Peterson, R A

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  7. Piraino, B

    1. Peritonitis influences mortality in peritoneal dialysis patients.
      L F Fried, J Bernardini, J R Johnston and B Piraino
      JASN October 1996, 7 (10) 2176-2182; DOI: https://doi.org/10.1681/ASN.V7102176

  8. Pollak, M R

    1. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred.
      M R Pollak, V B Delaney, R M Graham and S C Hebert
      JASN October 1996, 7 (10) 2244-2248; DOI: https://doi.org/10.1681/ASN.V7102244

R

  1. Raymond, J R

    1. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
      E C Kovalik, J R Raymond, F J Albers, M Berkoben, D W Butterly, B Montella and P J Conlon
      JASN October 1996, 7 (10) 2264-2267; DOI: https://doi.org/10.1681/ASN.V7102264

  2. Reif, M

    1. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
      L A Hebert, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain and A Agarwal
      JASN October 1996, 7 (10) 2130-2134; DOI: https://doi.org/10.1681/ASN.V7102130

  3. Remuzzi, G

    1. The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes.
      N Perico, S Amuchastegui, M Bontempelli and G Remuzzi
      JASN October 1996, 7 (10) 2254-2258; DOI: https://doi.org/10.1681/ASN.V7102254

  4. Revert, L

    1. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
      R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert and X Estivill
      JASN October 1996, 7 (10) 2142-2151; DOI: https://doi.org/10.1681/ASN.V7102142

S

  1. Sander, K

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

  2. Schievink, W I

    1. Follow-up of intracranial aneurysms in autosomal dominant polycystic kidney disease by magnetic resonance angiography.
      J Huston, V E Torres, D O Wiebers and W I Schievink
      JASN October 1996, 7 (10) 2135-2141; DOI: https://doi.org/10.1681/ASN.V7102135

  3. Shaldon, S

    1. Bactericidal/permeability increasing factors.
      S Shaldon
      JASN October 1996, 7 (10) 2268; DOI: https://doi.org/10.1681/ASN.V7102268

  4. Shimada, K

    1. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells.
      M Ikeda, U Ikeda, M Takahashi, K Shimada, S Minota and S Kano
      JASN October 1996, 7 (10) 2213-2218; DOI: https://doi.org/10.1681/ASN.V7102213

  5. Simmens, S J

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  6. Smith-Wheelock, L

    1. Why is it difficult for staff to discuss advance directives with chronic dialysis patients?
      E Perry, R Swartz, L Smith-Wheelock, J Westbrook and C Buck
      JASN October 1996, 7 (10) 2160-2168; DOI: https://doi.org/10.1681/ASN.V7102160

  7. Soucie, J M

    1. Early death in dialysis patients: risk factors and impact on incidence and mortality rates.
      J M Soucie and W M McClellan
      JASN October 1996, 7 (10) 2169-2175; DOI: https://doi.org/10.1681/ASN.V7102169

  8. Sugiyama, H

    1. Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation.
      Y Maeshima, N Kashihara, H Sugiyama, H Makino and Z Ota
      JASN October 1996, 7 (10) 2219-2229; DOI: https://doi.org/10.1681/ASN.V7102219

  9. Sundaram, S

    1. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
      S Sundaram, T W Barrett, K B Meyer, C Perrella, M C Neto, A J King and B J Pereira
      JASN October 1996, 7 (10) 2183-2191; DOI: https://doi.org/10.1681/ASN.V7102183

  10. Sutters, M

    1. Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management.
      M Sutters, C L Gaboury and W M Bennett
      JASN October 1996, 7 (10) 2056-2061; DOI: https://doi.org/10.1681/ASN.V7102056

  11. Swartz, R

    1. Why is it difficult for staff to discuss advance directives with chronic dialysis patients?
      E Perry, R Swartz, L Smith-Wheelock, J Westbrook and C Buck
      JASN October 1996, 7 (10) 2160-2168; DOI: https://doi.org/10.1681/ASN.V7102160

T

  1. Takahashi, M

    1. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells.
      M Ikeda, U Ikeda, M Takahashi, K Shimada, S Minota and S Kano
      JASN October 1996, 7 (10) 2213-2218; DOI: https://doi.org/10.1681/ASN.V7102213

  2. Teng, P R

    1. Extracellular matrix distribution and hillock formation in human mesangial cells in culture without serum.
      W F Glass, P R Teng and L B Haney
      JASN October 1996, 7 (10) 2230-2243; DOI: https://doi.org/10.1681/ASN.V7102230

  3. Topley, N

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192

  4. Torra, R

    1. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
      R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert and X Estivill
      JASN October 1996, 7 (10) 2142-2151; DOI: https://doi.org/10.1681/ASN.V7102142

  5. Torres, V E

    1. Follow-up of intracranial aneurysms in autosomal dominant polycystic kidney disease by magnetic resonance angiography.
      J Huston, V E Torres, D O Wiebers and W I Schievink
      JASN October 1996, 7 (10) 2135-2141; DOI: https://doi.org/10.1681/ASN.V7102135

U

  1. Umana, W O

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

V

  1. Vaziri, N D

    1. Antithrombin III inhibits mesangial cell proliferation.
      M V Pahl, N D Vaziri, F Oveisi, J Wang and Y Ding
      JASN October 1996, 7 (10) 2249-2253; DOI: https://doi.org/10.1681/ASN.V7102249

  2. Veis, J H

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  3. Volpini, V

    1. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
      R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert and X Estivill
      JASN October 1996, 7 (10) 2142-2151; DOI: https://doi.org/10.1681/ASN.V7102142

W

  1. Wang, J

    1. Antithrombin III inhibits mesangial cell proliferation.
      M V Pahl, N D Vaziri, F Oveisi, J Wang and Y Ding
      JASN October 1996, 7 (10) 2249-2253; DOI: https://doi.org/10.1681/ASN.V7102249

  2. Weihs, K L

    1. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, W O Umana, J A Kovac, S Alleyne, I Cruz and J H Veis
      JASN October 1996, 7 (10) 2152-2159; DOI: https://doi.org/10.1681/ASN.V7102152

  3. Westbrook, J

    1. Why is it difficult for staff to discuss advance directives with chronic dialysis patients?
      E Perry, R Swartz, L Smith-Wheelock, J Westbrook and C Buck
      JASN October 1996, 7 (10) 2160-2168; DOI: https://doi.org/10.1681/ASN.V7102160

  4. Wiebers, D O

    1. Follow-up of intracranial aneurysms in autosomal dominant polycystic kidney disease by magnetic resonance angiography.
      J Huston, V E Torres, D O Wiebers and W I Schievink
      JASN October 1996, 7 (10) 2135-2141; DOI: https://doi.org/10.1681/ASN.V7102135

  5. Williams, J D

    1. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines.
      A Jörres, K Ludat, J Lang, K Sander, G M Gahl, U Frei, K DeJonge, J D Williams and N Topley
      JASN October 1996, 7 (10) 2192-2201; DOI: https://doi.org/10.1681/ASN.V7102192
Back to top

In this issue

View Selected Citations (0)